ACR/ARHP - Preview 2008 - (Page 5) Preview daily News 5 ACR/ARHP Annual Scientific Meeting | October 24 – 29, 2008 Pre-conference courses continued from page 3 out of rheumatologists concerned with translational issues, as well as basic scientists. “What we’re learning about these cells hopefully will teach us a lot about why people get autoimmune disease,” Dr. O’Shea said. “It’s a very fast-moving and exciting development in immunology.” “Nurse practitioners and physician assistants are trained in their programs as generalists,” said Kori Dewing, ARNP, MN, moderator of the examination sessions. “This course will teach some of the things that you can’t just read online — that you have to see, touch, and feel.” The day will begin with a discussion and demonstrations of adult and pediatric musculoskeletal examinations, followed by breakout sessions where attendees can try their new skills on each other and patients. “We’ve arranged to have some patients who have some of these very specific abnormalities and changes present at our conference so attendees can feel what synovitis or other changes in the joints feel like,” Dewing said. Attendees will also learn to use tools such as the HAQ and DAS28 to measure disease activity. Another session will focus on joint injections, including hands-on practice at finding the injection sites on fellow attendees. “We really want people to learn this knowledge in a practical way so that it’s useful at the end of the day,” Dewing said. AcR Review course The ACR Review Course will examine more than eight rheumatic diseases. The course is designed to allow clinicians to hear the latest expert opinions and immediately translate them to patient interventions. Mary E. Cronin, MD Kori Dewing, ARNP, MN Topics covered this year will include Beçhet’s syndrome and difficult gout. Beçhet’s is often difficult for rheumatologists to diagnose because they see it so rarely in their offices. The growth of difficult gout cases due to obesity and the increasing prevalence of organ transplantation has also created some difficulty for rheumatologists. The course will review the diagnosis and treatment options for both conditions. Other conditions to be covered this year include juvenile rheumatoid arthritis, atherosclerosis, vasculitis, systemic lupus erythematosus, myositis, and scleroderma. “Over the years the Review Course keeps getting better and better,” said Mary E. Cronin, MD, who will co-moderate this year’s course with John H. Stone, MD, MPH. “Rheumatologists are good at taking care of general patients with rheumatoid arthritis, but it’s when these difficult cases come up that we need experts to summarize the latest treatments. That’s why we offer this particular course.” Program Objectives The ACR Review Course will be held from Upon completion of this activity, participants 8:00 am – 4:30 pm on Saturday, October 25. will be better able to: Tuesday, October 28, 2008 Registration and Dinner – 6:30 PM San Francisco Marriott Yerba Buena Salons 1-8 San Francisco, CA ARHP clinical focus course Saturday’s ARHP Clinical Focus Course is designed to teach health practitioners the basic skills needed to work in a rheumatology practice. The course was developed as a hands-on adjunctive to an online post-graduate program, but attendees not involved in the online portion are also welcome to attend the course. ACR/ARHP Daily News is published by TriStar Publishing, Inc., as a service to the members of the American College of Rheumatology. All rights reserved. American College of Rheumatology David A. Fox, MD, FRCPC ACR President Kimberly F. Kimpton, PT ARHP President Brian F. Mandell, MD, PhD Chair, ACR Annual Meeting Planning Committee Benjamin J. Smith, PA-C Chair, ARHP Program Committee Tammy J. Tilley Senior Director, Communications, Marketing and Membership Erin Latimer Senior Specialist, Communications and Marketing TriStar Publishing, Inc. 7285 W. 132nd Street, Suite 300 Overland Park, KS 66213 Phone: 913-491-4200 Fax: 913-491-4202 www.tristarpub.com • Improve your understanding about the inflammatory role of IL-6 in RA pathogenesis and the link to cardiovascular disease • Evaluate the efficacy and safety of anti-IL-6 in the treatment of patients with RA • Integrate into practice new medical management strategies for patients who do not respond, become intolerant, or lose response to conventional anti-TNF agents Target Audience Community- and hospital-based rheumatologists and internal medicine physicians. Agenda 6:30 PM Registration & Dinner 7:00 PM Welcome & Introduction Edward C. Keystone, MD, FRCP(C) Professor of Medicine University of Toronto Toronto, Canada 7:05 PM Moving Beyond TNF: New Targets of Therapy Ernest H.S. Choy, MD, FRCP Consultant and Clinical Reader in Rheumatology King’s College London, England 7:25 PM RA-Associated Inflammatory Cytokines and the Link to Cardiovascular Disease Paul M. Ridker, MD, MPH, FACC, FAHA Eugene Braunwald Professor of Medicine Harvard Medical School Boston, Massachusetts 7:45 PM Anti-IL-6 in Rheumatoid Arthritis Treatment IL-6 Inhibition and Clinical Efficacy in RA Treatment Josef S. Smolen, MD Professor of Medicine Medical University of Vienna Vienna, Austria IL-6 Inhibition and Safety in RA Treatment Arthur F. Kavanaugh, MD Professor of Medicine University of California, San Diego School of Medicine San Diego, California 8:15 PM Incorporating the Next Generation of Biologic Therapy Into Practice: The Big Picture Edward C. Keystone, MD, FRCP(C) 8:35 PM Clinical Management Challenges With Biologic Agents: Interactive Faculty Roundtable Discussion/Audience Q&A 9:00 PM Adjourn Dessert and coffee with faculty Accreditation This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME and Alliance Medical Communications. The American Academy of CME is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation The American Academy of CME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Per regulatory guidelines, the educational grant used to support this activity may only be used for medical professionals attending the presentation. Our grant funding does not allow for participation by non-healthcare providers and/or guests. Registration There is no fee to attend the symposium; however, seating is limited. Registration is available online at http://meetings.alliancemedcom.com/IL6 Look for your invitation in the mail and proceedings from this CME-certified symposium published as an enduring activity supplement in the April 2009 issue of The Rheumatologist. Services for the Disabled If special arrangements are required for an individual to attend this program, please contact Alliance Medical Communications at 610-696-8350. This is not an official program of the American College of Rheumatology. Jointly sponsored by Supported by an independent educational grant from http://meetings.alliancemedcom.com/IL6 http://meetings.alliancemedcom.com/IL6 http://www.tristarpub.com
Table of Contents Feed for the Digital Edition of ACR/ARHP - Preview 2008 ACR/ARHP - Preview 2008 ACR/ARHP - Preview 2008 - (Page 1) ACR/ARHP - Preview 2008 - (Page 2) ACR/ARHP - Preview 2008 - (Page 3) ACR/ARHP - Preview 2008 - (Page 4) ACR/ARHP - Preview 2008 - (Page 5) ACR/ARHP - Preview 2008 - (Page 6) ACR/ARHP - Preview 2008 - (Page 7) ACR/ARHP - Preview 2008 - (Page 8)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.